4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)

C133H163F6N25O5S6 — CID 159075524

IUPAC4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)
SMILESCN1CCC(c2csc(-c3c[nH]c4ncc(C5CCC(N6CCOCC6)CC5)cc34)n2)CC1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCCC5)CC4)cc23)cs1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCCOCC5)CC4)cc23)cs1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCCOCC5)CC4)cc23)cs1.FC(F)(F)c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1.FC(F)(F)c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1
InChIInChI=1S/C26H35N5OS.2C22H28N4OS.2C21H23F3N4OS.C21H26N4S/c1-30-8-6-19(7-9-30)24-17-33-26(29-24)23-16-28-25-22(23)14-20(15-27-25)18-2-4-21(5-3-18)31-10-12-32-13-11-31;2*1-15-25-21(14-28-15)20-13-24-22-19(20)11-17(12-23-22)16-3-5-18(6-4-16)26-7-2-9-27-10-8-26;2*22-21(23,24)18-12-30-20(27-18)17-11-26-19-16(17)9-14(10-25-19)13-1-3-15(4-2-13)28-5-7-29-8-6-28;1-14-24-20(13-26-14)19-12-23-21-18(19)10-16(11-22-21)15-4-6-17(7-5-15)25-8-2-3-9-25/h14-19,21H,2-13H2,1H3,(H,27,28);2*11-14,16,18H,2-10H2,1H3,(H,23,24);2*9-13,15H,1-8H2,(H,25,26);10-13,15,17H,2-9H2,1H3,(H,22,23)
InChIKeyKAEUHPCBVORBEQ-UHFFFAOYSA-N
MW2498.33 g/mol
LogP29.58
Rot. Bonds19

About 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)

4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) (PubChem CID 159075524) has the molecular formula C133H163F6N25O5S6 and a molecular weight of 2498.33 g/mol. Its IUPAC name is 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine).

Molecular Properties

Compound Name4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)
PubChem CID159075524
Molecular FormulaC133H163F6N25O5S6
Molecular Weight2498.33 g/mol
Exact Mass2496.15
IUPAC Name4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)
SMILESCN1CCC(c2csc(-c3c[nH]c4ncc(C5CCC(N6CCOCC6)CC5)cc34)n2)CC1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCCC5)CC4)cc23)cs1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCCOCC5)CC4)cc23)cs1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCCOCC5)CC4)cc23)cs1.FC(F)(F)c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1.FC(F)(F)c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1
InChIInChI=1S/C26H35N5OS.2C22H28N4OS.2C21H23F3N4OS.C21H26N4S/c1-30-8-6-19(7-9-30)24-17-33-26(29-24)23-16-28-25-22(23)14-20(15-27-25)18-2-4-21(5-3-18)31-10-12-32-13-11-31;2*1-15-25-21(14-28-15)20-13-24-22-19(20)11-17(12-23-22)16-3-5-18(6-4-16)26-7-2-9-27-10-8-26;2*22-21(23,24)18-12-30-20(27-18)17-11-26-19-16(17)9-14(10-25-19)13-1-3-15(4-2-13)28-5-7-29-8-6-28;1-14-24-20(13-26-14)19-12-23-21-18(19)10-16(11-22-21)15-4-6-17(7-5-15)25-8-2-3-9-25/h14-19,21H,2-13H2,1H3,(H,27,28);2*11-14,16,18H,2-10H2,1H3,(H,23,24);2*9-13,15H,1-8H2,(H,25,26);10-13,15,17H,2-9H2,1H3,(H,22,23)
InChIKeyKAEUHPCBVORBEQ-UHFFFAOYSA-N
XLogP29.58
TPSA318.25 Ų
H-Bond Donors6
H-Bond Acceptors30
Rotatable Bonds19
Heavy Atoms175
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002498.33
LogP ≤ 529.58
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1030

Analyze 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)?
The IUPAC name of 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) (CID 159075524) is 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine).
What is the SMILES notation for 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)?
The canonical SMILES for 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) is CN1CCC(c2csc(-c3c[nH]c4ncc(C5CCC(N6CCOCC6)CC5)cc34)n2)CC1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCCC5)CC4)cc23)cs1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCCOCC5)CC4)cc23)cs1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCCOCC5)CC4)cc23)cs1.FC(F)(F)c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1.FC(F)(F)c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1.
What is the InChIKey of 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)?
The InChIKey is KAEUHPCBVORBEQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H35N5OS.2C22H28N4OS.2C21H23F3N4OS.C21H26N4S/c1-30-8-6-19(7-9-30)24-17-33-26(29-24)23-16-28-25-22(23)14-20(15-27-25)18-2-4-21(5-3-18)31-10-12-32-13-11-31;2*1-15-25-21(14-28-15)20-13-24-22-19(20)11-17(12-23-22)16-3-5-18(6-4-16)26-7-2-9-27-10-8-26;2*22-21(23,24)18-12-30-20(27-18)17-11-26-19-16(17)9-14(10-25-19)13-1-3-15(4-2-13)28-5-7-29-8-6-28;1-14-24-20(13-26-14)19-12-23-21-18(19)10-16(11-22-21)15-4-6-17(7-5-15)25-8-2-3-9-25/h14-19,21H,2-13H2,1H3,(H,27,28);2*11-14,16,18H,2-10H2,1H3,(H,23,24);2*9-13,15H,1-8H2,(H,25,26);10-13,15,17H,2-9H2,1H3,(H,22,23).
What are the key properties of 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)?
4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) has a molecular weight of 2498.33 g/mol, XLogP of 29.58, 19 rotatable bonds, 6 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[3-[4-(1-methylpiperidin-4-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-methyl-4-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole;bis(4-[4-[3-(2-methyl-1,3-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]-1,4-oxazepane);bis(4-[4-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) is sourced from PubChem (CID 159075524), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).